|
3759
|
(aR)-RP-6306
|
(aR)-enantiomer of RP-6306 (Axon 3668); PKMYT1 inhibitor |
€180.00 |
|
3598
|
BAY-091 hydrochloride
|
First potent and highly selective PIP4K2A inhibitor |
€130.00 |
|
3760
|
Belzutifan
|
Second-generation potent, selective and orally active HIF-2α inhibitor |
€280.00 |
|
3763
|
CFT-7455
|
Orally active monofunctional degrader for IKZF1/3 |
Inquire |
|
3764
|
CFT-8634
|
Selective orally bioavailable BRD9 degrader |
Inquire |
|
3736
|
CGS 15943
|
Potent and selective adenosine antagonist |
€80.00 |
|
3765
|
DS-3032
|
Orally available, potent and selective inhibitor of the p53-MDM2 interaction |
Inquire |
|
3766
|
DT-2216
|
Selective B-cell lymphoma-extra large (Bcl-XL) targeted protein degrader |
Inquire |
|
3674
|
Ena21 hydrochloride
|
Selective and competitive ALKBH5 inhibitor |
€110.00 |
|
3769
|
FHD-286
|
Selective inhibitor of the BAF chromatin remodeling complex ATPases (BRG1/BRM) |
Inquire |
|
3767
|
GDC-1971
|
Orally available, potent, and selective inhibitor of the protein tyrosine phosphatase SHP2 |
Inquire |
|
3768
|
GDC-6036
|
Inhibitor of KRAS G12C |
Inquire |
|
3732
|
HBX 41,108
|
Inhibitor of deubiquitinase USP7 |
€90.00 |
|
3770
|
KSQ-2479
|
An allosteric, first-in-class USP1 (Ubiquitin Specific Protease 1) inhibitor |
Inquire |
|
3684
|
MRS 1220
|
Potent and selective hA3 receptor antagonist |
€140.00 |
|
3761
|
MRTX1133
|
First-in-class, noncovalent, selective & reversible inhibitor of KRASG12D mutant |
€220.00 |
|
3734
|
Norastemizole
|
H1 antagonist |
€140.00 |
|
3762
|
PF-07220060
|
Orally bioavailable and CDK4-Specific Inhibitor |
Inquire |
|
3639
|
PTX80
|
First-in-class inhibitor of protein degradation by targeting p62/SQSTM1 |
€120.00 |
|
3668
|
RP-6306
|
First-in-class, potent, selective, and orally bioavailable PKMYT1 inhibitor |
€140.00 |
|
3596
|
ZG-2033
|
Potent and orally bioavailable HIF-2α agonist |
€130.00 |
|
3735
|
ZZW-115 trihydrochloride
|
Potent NUPR1 inhibitor |
€140.00 |